Literature DB >> 1839310

A role for tumor necrosis factor in poly(I:C)-induced hemorrhagic necrosis and T-cell-dependent regression of a murine sarcoma.

R J North1, P L Dunn, E A Havell.   

Abstract

It was found that intravenous injection of the synthetic double-stranded ribonucleic acid, polyinosinic-polycytidylic acid [poly(I:C)], which is a well-studied interferon (IFN)-inducing agent, can result in extensive hemorrhagic necrosis of the center of an established murine sarcoma and in subsequent complete regression of the surviving rim of the tumor. The poly(I:C)-induced intratumor hemorrhagic reaction was associated with production of appreciable quantities of tumor necrosis factor (TNF) by the host. Neutralization of TNF by treatment with anti-rTNF immunoglobulin G (IgG) caused substantial inhibition of hemorrhagic necrosis and prevented tumor regression from proceeding. Tumor regression was prevented in all mice by depleting them of CD8+ T cells 1 day before poly(I:C) was given. Taken as a whole, the results indicate that the antitumor action of poly(I:C), like that of endotoxin, is based on its capacity to induce the host to make enough TNF to cause a hemorrhagic reaction extensive enough to reduce the tumor burden to a size capable of being dealt with by an underlying host antitumor immune response.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1839310     DOI: 10.1089/jir.1991.11.333

Source DB:  PubMed          Journal:  J Interferon Res        ISSN: 0197-8357


  5 in total

1.  Therapeutic Immune Modulation against Solid Cancers with Intratumoral Poly-ICLC: A Pilot Trial.

Authors:  Chrisann Kyi; Vladimir Roudko; Rachel Sabado; Yvonne Saenger; William Loging; John Mandeli; Tin Htwe Thin; Deborah Lehrer; Michael Donovan; Marshall Posner; Krzysztof Misiukiewicz; Benjamin Greenbaum; Andres Salazar; Philip Friedlander; Nina Bhardwaj
Journal:  Clin Cancer Res       Date:  2018-06-27       Impact factor: 12.531

Review 2.  Stimulating Innate Immunity to Enhance Radiation Therapy-Induced Tumor Control.

Authors:  Jason R Baird; Arta M Monjazeb; Omid Shah; Heather McGee; William J Murphy; Marka R Crittenden; Michael J Gough
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-04-19       Impact factor: 7.038

3.  Tumor suppression by Tegafur combined with Barbadian in S-180 tumor-bearing mice.

Authors:  Enning Zhang; Aiqin Fu; Weijun Chen; Xiaojie Wang
Journal:  Oncol Lett       Date:  2018-08-30       Impact factor: 2.967

4.  Tissue chambers--a useful model for in vivo studies of cytokine production in the pig.

Authors:  E Wattrang; P Wallgren; L Fuxler; M Lindersson; C Fossum
Journal:  Vet Immunol Immunopathol       Date:  1997-05       Impact factor: 2.046

5.  Precision spherical nucleic acids for delivery of anticancer drugs.

Authors:  Danny Bousmail; Lilian Amrein; Johans J Fakhoury; Hassan H Fakih; John C C Hsu; Lawrence Panasci; Hanadi F Sleiman
Journal:  Chem Sci       Date:  2017-07-05       Impact factor: 9.825

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.